Update-(NYSE-MKT: XXII) – This week
If your new with us, you may have missed the initial coverage of XXII in December so I thought we would bring you up to speed.
December 14th, 2015 initial XXII report over 200 patents on the tobacco plant proprietary value – http://smallcapstreet.com/xxii/
January 20th, 2016 FDA meeting and modified risk labeling- http://smallcapstreet.com/xxii-fdameeting/
Should we see an FDA approval for modified risk labeling, the catalyst in our opinion becomes either a buyout by someone like British American Tobacco which already has a licensing deal with 22nd Century Group ( http://www.businesswire.com/news/home/20131001007113/en/British-American-Tobacco-Licenses-22nd-Century-Group ) or a joint venture with one of the bigger players in the industry.
If you have not read all of our coverage of XXII to date, please take a moment to do so.
There has been a lot of talk on the street about the opportunity in Small Caps this week. As I write this I can remember it being a big topic of discussion late Friday on CNBC.
As always we are scanning this sector daily looking for new opportunities for our group. We should be announcing a new profile soon, stay tuned.
VIP SMS/TEXT SERVICE
If you are receiving emails only, they can be unreliable. You may want to consider our free VIP SMS/text alert service by simply sending a text from your cell phone to the number 25827 in the message section just type in the word “Street”. Opt out anytime as always there is no obligation.